The interaction of normal and acute-phase high-density lipoproteins of the subclass 3 (N-HDL3 and AP-HDL3) with human neutrophils and the accompanying degradation of HDL3 apolipoproteins have been studied in vitro. The chemical composition of normal and acute-phase HDL3 was similar except that serum amyloid A protein (apo-SAA) was a major apolipoprotein in AP-HDL3 (approx. 30 % of total apolipoproteins). "25I-labelled AP-HDL3 was degraded 5-10 times faster than "25I-labelled N-HDL3 during incubation with neutrophils or neutrophil-conditioned medium. Apo-SAA, like apolipoprotein A-II (apo-A-1I), was more susceptible than apolipoprotein A-I (apo-A-I) to the action of proteases released from the cells. The amounts of cell-associated AP-HDL3 apolipoproteins at saturation were up to 2.8 times greater than N-HDL3 apolipoproteins; while apo-A-I was the major cell-associated apolipoprotein when N-HDL3 was bound, apo-SAA constituted 80 % of the apolipoproteins bound in the case of AP-HDL3. The associated intact apo-SAA was mostly surface-bound as it was accessible to the action of exogenous trypsin.
INTRODUCTION
Apo-SAA and C-reactive protein are the two proteins in man whose concentrations increase most dramatically during an acute-phase reaction. Plasma levels are elevated up to 100-fold following inflammation, infarction or infection [1] . This change is probably produced as a result of the release from macrophages of interleukin I, which alters hepatic protein synthesis [2] . In contrast with C-reactive protein, whose biological role seems to be the complement-dependent solubilization of chromatin following cell death [3] , the function of apo-SAA is unknown. As some apolipoproteins have been shown to act as targeting devices for receptor-mediated cellular uptake and in others as enzymatic co-factors, further studies on the cellular interactions and metabolism of apo-SAA are essential to elucidate its function [5] . Most previous work on apo-SAA has focused on its proteolytic degradation in relation to amyloidogenesis [4, 5] . Only in rare instances during chronic inflammation does the aberrant degradation of apo-SAA (Mr 12000) yield a cleavage product called amyloid A protein (Mr 8000) that polymerizes pathogenetically to amyloid fibrils [6] . The occurrence of apo-SAA in the plasma is probably of functional importance in inflammatory processes of different kinds irrespective of whether they are complicated by amyloidosis.
Neutrophil leukocytosis is a concomitant of the acutephase response and the deposition of murine amyloid is accelerated by it [7] . Previous studies have shown that purified apo-SAA is degraded by neutrophil-derived proteolytic enzymes amongst which is an elastase that has been shown to play an important role [4] . The enzyme that cleaves apo-A-II upon incubation of normal human HDL3 with neutrophils is also an elastase [8] . The degradation of both apo-A-II and apo-SAA is inhibited by al-AT and other elastase inhibitors [4, 8] .
Apo-SAA exists in the plasma almost exclusively as an apolipoprotein of HDL3 [9] . It should be noted that AP-HDL3 represents a, polydisperse population of particles that differ with respect to density, size and apolipoprotein composition [10] . In this study we have investigated the association with neutrophils of N-HDL3 and AP-HDL3 and have examined the influence of this association on the degradation of apo-SAA and other HDL3 apolipoproteins. Our results show that apo-SAA, like apo-A-II, is highly susceptible to degradation by neutrophil-derived proteases. In addition, significantly more AP-HDL3 protein associates with neutrophils than N-HDL3 protein. Apo-SAA constitutes more than 80% of the cell-associated AP-HDL3 apolipoproteins. In the presence of al-AT, the significant cellular degradation of AP-HDL3 apolipoproteins (predominantly apo-SAA) is likely to be an event that occurs at the surface. ml of blood) by Hypaque/Ficoll gradient centrifugation [11] ; contaminating red blood cells were lysed by hypotonic shock. Cell viability was greater than 98 % as determined by Trypan Blue exclusion, and WrightGiemsa stains showed greater than 98 % cell purity. Cells (suspended at 40 x 106 cells/ml of RPMI 1640) (GIBCO, Grand Island, NY, U.S.A.) were kept on ice and used within 1 h of preparation. HDL3 preparation and iodination Plasma was collected, as previously described [10] , from normal adults for the preparation of N-HDL3 and from patients with myocardial infarction, bacterial pneumonia or after abdominal surgery, for preparation of AP-HDL3. An HDL3 fraction with a density of 1.13-1.18 g/ml was obtained by discontinuous gradient ultracentrifugation as previously described [10, 12] . Protein was determined by the Lowry method [13] , using bovine serum albumin (Fraction V; Miles Laboratories) as a standard. HDL3 composition and the relative content of apolipoproteins was determined as previously described [10, 12] . The apolipoprotein (apo-A-I, apo-A-II, apo-SAA) and lipid composition of three normal and four acute-phase HDL3 batches used in this study are shown in Table 1 . Except for the apolipoprotein profiles, no significant differences between AP-and N-HDL3 were observed. lodination of lipoproteins was done by a modified iodine monochloride method using [125I]NaI (Amersham International) [14] . Neutrophil association and degradation of 125I-labelied N-HDL3 and 125I-labelled AP-HDL3 1.5 mg/ml). Prior titration confirmed that this al-AT concentration (1.5 mg/ml) was unequivocally on a plateau of inhibition with respect to AP-HDL3 degradation for all conditions described. The medium was supplemented with bovine serum albumin to give a final (a,-AT plus bovine serum albumin) protein concentration of 2 mg/ml. The incubation with HDL3 was done according to the regimes described in the Results section. Reactions were stopped by centrifugation at 2000 rev./ min for 4 min at 4 'C. Cell-free supernatants (1 ml portions) were immediately precipitated with trichloroacetic acid at a final concentration of 12% (w/v). Inorganic iodide from trichloroacetic acid-soluble material was extracted with CHCl3 following oxidation with H202 [15] . This procedure eliminated any inorganic iodide that existed in the 125I-labelled HDL3 preparation (<1 % of the total added radioactivity) and any iodide that was released during the incubation.
The cells were washed at 4 'C by centrifugation, once with 10 mM-phosphate-buffered saline (pH 7.4) containing 0.2% (w/v) bovine serum albumin, and twice with the same buffer but without bovine serum albumin. With the final wash, cells were transferred to clean tubes. Total radioactivity associated with the cells was determined by gamma counting (LKB gamma counter, LKB Instruments, Turku, Finland). The results are averages of duplicate incubations ( Fig. 2 and Fig. 3 ). Duplicates did not differ by more than 12% from each other. In some experiments, the nature of the associated apolipo- [16] . Cell-conditioned medium was also obtained from neutrophils to investigate the degradation of 'l25-labelled N-HDL3 and '25I-labelled AP-HDL3 by secreted proteases. Cell-conditioned medium was prepared by incubating 10 x 106 neutrophils in 2 ml of standard incubation medium containing a,-AT and bovine serum albumin but without HDL3 present. The cell-free cellconditioned medium was mixed with 1251-labelled N-HDL3 or 1251-labelled AP-HDL3 within 5 min of collection and the reaction conditions were as described in the Results section. Incubation mixtures were analysed for the generation of trichloroacetic acid/soluble degradation products or by SDS/polyacrylamide-gel electrophoresis and autoradiography as described above.
In other experiments, after incubation of cells with "25I-labelled AP-HDL3 (25 ,ug/ml, 60 min, 37°C), the fate of the associated "25I-labelled AP-HDL3 was investigated. The cells (10 x 106) were first washed in phosphate-buffered saline (4°C) by two brief (< 30 s) centrifugation steps in a Microfuge (Beckman Instruments, La Jolla, CA) and then incubated at 37°C in HDL3-free medium (2 ml) containing z1-AT and bovine serum albumin (as indicated above) for various time periods (pulse-chase experiments). Cell-associated radioactivity and radioactivity released into the medium were determined at the end of the chase times.
Surface-bound radioactivity was determined by treating the cells at the end of incubation periods or at the end Neutrophil metabolism of acute-phase high-density lipoprotein Table 2 . Effect of a,-AT on the association and degradation of HDL3 by neutrophils Incubations were carried out with 10 x 106 cells and 125I-labelled HDL3 (25 jug of protein/ml) for 60 min at 37 IC in the absence (-) or presence (+) of a1-AT (1.5 mg/ml). The results of three experiments using three different batches each of 251I-labelled N-HDL3 and 251I-labelled AP-HDL3 and neutrophils from three different subjects are given. released into the medium and radioactivity remaining with the cells were then determined as before.
Influence of AP-HDL3 and N-HDL3 on release of neutrophil proteolytic enzymes The influence of N-HDL3 or AP-HDL3 on the release of proteolytic enzymes was studied essentially as described by Polacek et al. [21] . This involved evoking the release of proteolytic enzymes by the respective HDL3 preparations, followed by ultracentrifugal flotation of the HDL3 and recovery of proteolytic activity in the infranatants. Specifically, 80 x 106 neutrophils were incubated in 5 ml of RPMI 1640/25 mM-Hepes buffer (pH 7.4) containing either 1 mg of AP-HDL3/ml, 1 mg of N-HDL3/ml or no HDL3 (control). Incubations were in sterile Greiner polycarbonate tubes for 60 min at 37 'C. At the end of the incubation, cells were spun at 2000 rev./min; the density of 4 ml of each of the respective supernatants was increased to 1.25 g/ml with KBr, and they were layered under 2 ml of KBr (1.21 g/ ml) and spun for 38 h at 45000 rev./min in a Beckman T65 rotor at 10 'C. The upper 2 ml containing the HDL3 was removed and the infranatants containing the released proteases were dialysed against 0.15 M-NaCl/ 0.02% azide, pH 7.0. The three infranatants constituting 'N-HDL3-conditioned medium', 'AP-HDL3-conditioned medium' and 'control-conditioned medium' were obtained, and medium from 2 x 106 cells, were each incubated in triplicate with l25l-labelled AP-HDL3 or 125I-labelled N-HDL3, and apolipoprotein degradations were determined as described above.
RESULTS
The influence of a.-AT on cell-association and degradation of 125I-labelled HDL3 Physiological interactions between HDL3 and neutrophils occur in the presence of a,-AT. Given the known susceptibility of apo-A-II [8] and purified apo-SAA [4] to proteolytic cleavage by elastases, the influence of acL-AT I phoresis of reaction products followed by autoradiography (Fig. 1) . In the absence of a1-AT, apo-A-II of N-HDL3 was degraded almost completely to a band of approx. Mr 7000 after a 2.5 h incubation with cellconditioned medium (Fig. 1, track 2) . Further incubation for up to 18 h did not substantially alter the pattern of protein bands except for some degradation of apo-A-I (Fig. 1, track 4) . In the case of AP-HDL3, both apo-A-II and apo-SAA were completely degraded by 2.5 h, with apo-A-I remaining apparently resistant in the absence of al-AT in the medium (Fig. 1, track 7) . However, definite degradation of apo-A-I was visible by 18 h under these conditions (Fig. 1, track 9) . No low-M, protein fragments or amyloid A-like protein band was detected even during shorter incubation times (results not shown). With cxl-AT present in the medium, no degradation of apo-A-I or apo-A-II on the N-HDL3 particles was apparent even after incubation for 18 h (Fig. 1, tracks 3 and 5) . Apo-A-II and apo-SAA on AP-HDL3 were not visibly degraded after a 2.5 h incubation with al-AT (Fig. 1, track 8 ), but some degradation of these apolipoproteins was clearly detected by 18 h (Fig. 1, track 10 ). Degradation of apo-A-I on the AP-HDL3 particles was not visible even after incubation for up to 18 h (Fig. 1, track 10 ). This pattern of degradation was observed in the case of three different batches of N-HDL3 and AP-HDL3. All further experiments were carried out in the presence of a1-AT (1.5 mg/ml). The cell-association of both "25I-labelled N-HDL3 and '25I-labelled AP-HDL3 approached a steady-state at 60 min (Fig. 2a) , and was a saturable process, as shown by concentration-dependence curves (Fig. 3a) . The level of associated '25I-labelled AP-HDL3 material was greater than that of '251-labelled N-HDL3 at any comparable concentration tested. Cell-associated 1251-labelled HDL3 comprised both trypsin-removable and trypsin-resistant proteins. In the case of 125I-labelled AP-HDL3, the trypsin-resistant radioactivity was greater than in that of '25I-labelled N-HDL3 (Figs. 2b and 3b) , confirming results presented in Table 2 . Production of degradation products was detectable within 2 min of incubating 1251_ labelled HDL3 with neutrophils (Fig. 2c) . The production of iodide-free degradation products from both ligands was linear for up to 90 min (Fig. 2c) and the rate of degradation of 251I-labelled AP-HDL3 was greater than that of 1251-labelled N-HDL3. The degradation rates of 125I-labelled HDL3 approached saturation at high concentrations of 1251-labelled HDL3 (Fig. 3c) .
The contribution of proteases released from cells to the degradation of 1251-HDL3 was investigated to ascertain whether a cell-mediated proteolytic component exists in addition to proteases released into the medium as demonstrated by the action of al-AT (see above). Far fewer iodide-free degradation products were produced ( Fig. 2d and 3d ) by the cell-free system (cell-conditioned medium) than were released in the presence of cells (Fig. 2c and 3c) .
The differences between AP-HDL3 and N-HDL3 with respect to the above-mentioned parameters were consistent features when neutrophils from six different subjects, and HDL3 preparations from three normal and iodide-free degradation products, (d) iodide-free degradation products generated by incubating cell-conditioned medium (prepared from 10 x 106 cells, various time intervals) with 1251-labelled HDL3 for time periods equivalent to that of the production of this medium.
four acute-phase patients, were used in similar experiments. For example, the cell-association of AP-HDL3 was 2.84 (±0.14)fold (n = 15) higher than that of N-HDL3, and the corresponding degradation rate was Vol. 248 Influence of AP-HDL3 and N-HDL3 on release of proteolytic enzymes from neutrophils during cellular degradation of HDL3 Linear concentration-dependent release by N-HDL3 of an elastase with proteolytic activity directed against apo-A-II from neutrophils has been described [8, 21] . In order to clarify the observed cell-associated degradation of HDL3 (Figs. 2c, 2d, 3c and 3d) , we measured the release from neutrophils of proteolytic enzymes capable of degrading AP-HDL3 apolipoproteins (especially apo-SAA). Although only 25 ,ug of HDL3/ml was available to elicit release during cell-associated degradation experiments, the results in Table 3 show the influence of 1 mg each of AP-HDL3 or N-HDL3/ml on the release of proteolytic enzymes. Even at these high concentrations of HDL3, the release of enzymes by either AP-HDL3 or N-HDL3 could not fully account for the observed rates of total cellular degradation (Figs. 2c, 2d, 3c and 3d) . Enzymes released by AP-HDL3 or by N-HDL3 resulted in about 30 % and 90 % increases in the degradation of AP-HDL3, in the absence and presence of a,-AT respectively. Total cellular degradation rates of 1251-labelled AP-HDL3 (when 1 mg of HDL3/ml was available to evoke release of proteolytic enzymes) were about three times higher than those brought about by conditioned medium lacking a.,-AT and about 15 times higher when al-AT was present (Table 3) . No proteolytic activity was lost during the different steps employed to prepare the conditioned medium, since similar degradation rates of 125I-labelled AP-HDL3 were obtained when freshly-prepared conditioned medium (in the absence of HDL3) was compared with conditioned medium subjected to all the preparation steps referred to above ('control conditioned medium'). These findings therefore suggested than an al-AT-resistant cellular proteolytic component was present in the overall degradation of HDL3 apolipoproteins by neutrophils.
The possible contribution of lysosomes to the degradation of 125I-AP-HDL, during incubation with neutrophils was investigated using the lysosomotropic inhibitors chloroquine (100 /tM) and NH4Cl (25 mM) . No significant inhibitory effect on the production of iodide-free degradation products was found using either of these inhibitors of lysosomal function (results not shown). Nature of cell-associated apolipoproteins Apo-A-I was the major cell-associated apolipoprotein when 125I-labelled N-HDL3 was incubated with neutrophils (Fig. 4a) . When 1251-labelled AP-HDL3 was used (Fig. 4b) , however, apo-SAA was the predominant apolipoprotein associated with the cells. This apparently selective association of apo-SAA was reproducibly demonstrated by the binding of three different batches of 1251-labelled AP-HDL3 to three different neutrophil preparations for 60 min (Fig. 4d) . The enrichment of apo-SAA in cell-associated fractions was not due to apolipoproteins non-specifically associated to the reaction tubes (results not shown). The proportion of 1251-apo-SAA in the starting HDL3 was 36+5% (n= 3), whilst 82 + 7 % (n = 3) of the cell-associated apolipoprotein was '251-apo-SAA. Fig. 4(c) shows that following trypsinization, the cell-associated apo-SAA was mostly degraded when compared with untreated samples. This indicates that trypsin gained access to the intact cellassociated 1261-labelled apo-SAA, and confirms the cellsurface location of the associated 125I-apo-SAA. Table 3 . Influence of AP-HDL3 and N-HDL3 on the release of proteolytic enzymes from neutrophils Degradation is that of 5 ,ug of I251-labelled AP-HDL3 or 126I-labelled N-HDL3 (200 #1 of RPMI 1640; 60 min; 37°C ; with or without a,-AT; 1.5 mg/ml); by either 2 x 106 neutrophils (total), or conditioned media representing release from 2 x106 neutrophils (ultracentrifugal separation of HDL3 from medium after release). AP-HDL3, N-HDL3 and controls were used as described in the Experimental section to evoke proteolytic enzyme release. Fate of cell-associated 1251-labelied AP-HDL3 The fate of cell-associated 125I-labelled AP-HDL3 was studied in pulse-chase experiments. Cells were pulselabelled with 1251-labelled AP-HDL3 and then incubated in an HDL3-free medium at 37°C for various time periods. The results of a typical experiment are summarized in Fig. 5 . A rapid initial rate of release of 1251. labelled material was observed. Analysis of the integrity of the HDL3 protein that was released into the medium, measured by iodide-free degradation products in the chase medium, revealed that 85 % of the '251-labelled AP-HDL3 that was released was trichloroacetic acidprecipitable ( Fig. 5 ) and detectable as intact apo-SAA on SDS-gels (results not shown). A small but significant fraction of the released material was nevertheless recovered as trichloroacetic acid-soluble degradation products. Although + 50 % of the cell-associated material was not released from the cells even after prolonged post-incubation periods (1 h; Fig. 5 ), this material represented relatively degraded apo-SAA (Fig.  5 inset) . Less than 10% of the original cell-associated apo-SAA at zero time ( Fig. 5 inset, track 2) could be resolved as intact apo-SAA during any time of the chase period (Fig. 5 inset, tracks 3-5) . Less than 15 % of cellassociated material dissociated from the cells at 4°C in 5 min, indicating that only minimal losses of bound material occurred during the wash process (4°C, less than 3 min) employed between the pulse-and chaseincubation periods.
DISCUSSION
Apo-SAA, which is produced by the liver during the acute-phase response, exists in the plasma mainly as an apolipoprotein of HDL3 [9, 10] . It generally constitutes 15-50 % of the total HDL3 apolipoproteins but in extreme circumstances the percentage of apo-SAA can rise to 80% of the total HDL3-apolipoprotein content [17, 18] . Newly synthesized apo-SAA seems to associate with existing HDL3 in the circulation with resultant remodelling of the surface of such particles yielding larger HDL3 particles which are denser and depleted of apo-A-I [10, 18] . The protein-lipid ratios and lipid composition of AP-HDL3 and N-HDL3 are similar both in man [10] and monkey [19] .
As neutrophil leukocytosis occurs together with increases in plasma apo-SAA levels during the acutephase period [7] , our study has focused on a comparison The association of N-HDL3 with cells, including neutrophils, is believed to be apo-A-I mediated but the nature of this has not been completely resolved [20, 21] . Our results do show that when "25I-labelled N-HDL3 is associated with neutrophils, apo-A-I is the major apolipoprotein that can be visualized after SDS electrophoresis (Fig. 4a) . However, in the case of the association of 125I-labelled AP-HDL3 with neutrophils, apo-SAA is the predominant associating apolipoprotein. This association is apparently saturated at about 150 ,ug of total AP-HDL3 protein/ml. Scatchard analysis of the results is not feasible because of ligand degradation. It remains unresolved whether apo-SAA dissociates from the AP-HDL3 particle to bind to neutrophils or whether a subset of apo-SAA-rich particles preferentially bind to the cells. AP-HDL3 has been shown to be polydisperse with respect to apolipoprotein distribution; particles do exist where apo-SAA is the major apolipoprotein [10, 26] . In any event, our results may explain the observed greater metabolic turnover rate of apo-SAA compared with that of any other HDL3 apolipoprotein [23] [24] [25] .
In analysing the intact apo-SAA associated with neutrophils, it is obvious that although a fraction exists that is resistant to trypsin release, this is not likely to be intracellular as analysis after SDS-electrophoresis revealed degradation of the apo-SAA after exposure to trypsin, reflecting accessibility of surface-bound intact apo-SAA to this exogenous protease.
Pulse-chase experiments have shown a rapid loss from the cell of intact apo-SAA; a significant pool of relatively degraded apo-SAA remained associated with the neutrophils. The nature and function of this pool is unknown, Degradation of 1251-labelled N-HDL3 and '251-labelled AP-HDL3 by cell-conditioned medium revealed degradation of apo-A-II on 1251-labelled N-HDL3, as previously reported [8] , and apo-A-II and apo-SAA on 1251-labelled AP-HDL3. It thus seems likely that the greater degradation of 125I-labelled AP-HDL3 observed during association with neutrophils is due to the degradation of both apo-A-II and especially apo-SAA. The degradation rates of 125I-labelled HDL3 during association with cells and by cell-conditioned medium increase hyperbolically at increasing concentrations both of 1251I-labelled N-HDL3 and 1251I-labelled AP-HDL3.
Since degradation products are detectable within 2 min after the start of the 1251-labelled HDL3 incubations, it is unlikely to be the result of internal cellular catabolism. In addition, results from pulse-chase experiments and the inability of lysosomotropic inhibitors to affect degradation indicate that intracellular lysosomal processing, as suggested by Silverman et al. [4] , is not likely to contribute to the observed degradation, even though it has been shown that lysosomal neutrophil elastase can degrade lipid-free SAA [4] .
Some of our observed cell-mediated degradation could have been due to a concentration-dependent HDL3-mediated egress of elastase from neutrophils, which in the case of N-HDL3, has been reported to result in the degradation of apo-A-II [8] . We have found, however, that cellular degradation, in addition to being relatively alc-AT-resistant, is of such magnitude that 'conditioning' of the medium cannot fully account for it. Our findings rather point to degradation activity being at least partly Vol. 248 925 926 E. G. Shephard and others a cell-surface event, making it conceivable that membrane-associated enzymes play an important role in the degradation of apo-SAA and other apolipoproteins of HDL3. Lipid-free SAA has been shown to be degraded by an elastase residing on the surface of monocytes [5] and recently evidence of the existence of a neutral serine protease in the membranes of neutrophils has been found [22] . The exact mechanism of apo-SAA breakdown needs to be elucidated in view of the possible importance of such events in various pathological processes.
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